What is the primary mechanism of action of 5-aminosalicylic acid (5-ASA) in treating IBD?
Master all 25 flashcards
Study of anti-inflammatory drugs used in IBD, including their mechanisms, indications, and side effect profiles.
By mastering this deck, learners will understand the pharmacology, appropriate clinical use, and side effect management of 5-aminosalicylic acid (5-ASA) compounds and corticosteroids in inflammatory bowel disease, enabling informed therapeutic decisions in practice.
ℹ️ Educational Use Only: This flashcard deck is created by usersof our platform for their educational and study purposes. The content is not intended as medical advice, diagnosis, or treatment guidance. Always consult qualified healthcare professionals for medical decisions and verify information with authoritative medical sources.
Showing 20 of 25 cardsSample view
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the primary mechanism of action of 5-aminosalicylic acid (5-ASA) in treating IBD? | 5-ASA exerts its anti-inflammatory effects mainly by inhibiting cyclooxygenase (COX) and lipoxygenase pathways, reducing prostaglandin and leukotriene synthesis, and scavenging free radicals in the intestinal mucosa. | Think of 5-ASA as a local anti-inflammatory that targets eicosanoid pathways. |
| 2 | In which parts of the gastrointestinal tract are 5-ASA drugs most effective? | 5-ASA drugs are most effective in the colon and rectum, making them suitable for ulcerative colitis, especially distal disease. | Designed for distal inflammation—think of 'colonic' specificity. |
| 3 | Name two common formulations of 5-ASA used in clinical practice. | Sulfasalazine and mesalamine (mesalazine). Sulfasalazine is a prodrug that releases 5-ASA in the colon; mesalamine is available in various formulations for targeted delivery. | S for Sulfasalazine, M for Mesalamine. |
| 4 | What are the main indications for corticosteroid use in IBD? | Corticosteroids are used for inducing remission in moderate to severe IBD flares but are not suitable for maintenance therapy due to side effects. | Steroids for flare control, not long-term maintenance. |
| 5 | Name two corticosteroids commonly used in IBD management. | Prednisone and budesonide. | Budesonide has high first-pass metabolism, leading to fewer systemic effects. |
| 6 | Describe one key difference between systemic corticosteroids and budesonide in IBD treatment. | Budesonide has extensive first-pass metabolism, resulting in less systemic absorption and fewer systemic side effects compared to systemic corticosteroids like prednisone. | Budesonide = high local, low systemic effect. |
| 7 | What are common side effects associated with corticosteroid therapy? | Side effects include weight gain, osteoporosis, hyperglycemia, hypertension, mood changes, and increased infection risk. | Think of the 'steroid side effects' as systemic metabolic and immune alterations. |
| 8 | Which adverse effect is particularly associated with long-term corticosteroid use in IBD patients? | Osteoporosis and adrenal suppression. | Long-term steroids weaken bones and suppress natural cortisol production. |
| 9 | Why is 5-ASA generally preferred over corticosteroids for maintenance therapy in UC? | Because 5-ASA has a favorable safety profile and effectively maintains remission, whereas corticosteroids have significant side effects with long-term use. | Safety first—think of 5-ASA as a safer maintenance option. |
| 10 | What is a major limitation of corticosteroid therapy in IBD? | They do not promote mucosal healing and are associated with significant side effects when used long-term. | Steroids are for flare control, not healing. |
| 11 | How does the mechanism of 5-ASA contribute to its localized effect in the gut? | 5-ASA compounds are designed to release the active drug specifically in the colon, minimizing systemic absorption and targeting inflammation directly at the site. | Think of targeted delivery for localized action. |
| 12 | How can corticosteroid side effects be minimized in IBD treatment? | By using the lowest effective dose for the shortest duration possible, and employing alternative therapies for maintenance. | Steroids are powerful but dangerous—use responsibly. |
| 13 | What is the role of sulfasalazine in IBD therapy, and what are its notable side effects? | Sulfasalazine is a prodrug that releases 5-ASA in the colon; side effects include headache, nausea, reversible oligospermia, and hypersensitivity reactions. | Sulfasalazine's side effects are partly due to its sulfapyridine component. |
| 14 | Explain why corticosteroids are not suitable for long-term maintenance in IBD. | Due to the risk of serious side effects such as osteoporosis, hyperglycemia, and adrenal suppression, corticosteroids are not recommended for prolonged use. | Think of corticosteroids as for short-term flare control only. |
| 15 | What monitoring is recommended when patients are on corticosteroid therapy? | Monitoring includes blood pressure, blood glucose, bone density, signs of infection, and side effects like weight gain and mood changes. | Regular check-ups help catch side effects early. |
| 16 | Describe the main difference in the mechanism of action between 5-ASA and corticosteroids. | 5-ASA inhibits inflammatory pathways locally in the gut, primarily via enzyme inhibition and free radical scavenging, while corticosteroids suppress a broad range of inflammatory gene expression systemically. | Localized versus systemic anti-inflammatory effects. |
| 17 | Which patient population may particularly benefit from mesalamine formulations with targeted colon release? | Patients with distal ulcerative colitis, where localized delivery enhances efficacy and minimizes systemic exposure. | Targeted delivery for localized disease. |
| 18 | What are the key considerations when choosing between systemic corticosteroids and topical formulations in IBD? | Topical formulations are preferred for distal disease to minimize systemic side effects, while systemic corticosteroids are used for more extensive or severe disease. | Match the formulation to disease extent. |
| 19 | List one advantage of budesonide over prednisone in IBD management. | Budesonide has high first-pass metabolism, leading to fewer systemic side effects compared to prednisone. | High first-pass = fewer systemic effects. |
| 20 | What is the significance of the 'first-pass metabolism' of budesonide? | It reduces systemic absorption, thereby decreasing systemic side effects while delivering high local concentrations in the gut. | First-pass acts as a built-in safety feature. |
Note: This preview shows only the first 20 cards. The complete deck contains 25 total cards. Start studying to access all flashcards.
Master all 25 flashcards
Explore other decks you might find helpful